Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28301 - 28325 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	ATP8B4	79895	downregulated	Cytarabine results in decreased expression of ATP8B4 mRNA	15q21.2	A21886
Cytarabine	Approved Investigational	AXL	558	downregulated	Cytarabine results in decreased expression of AXL mRNA	19q13.2	A21886
Cytarabine	Approved Investigational	B4GALT7	11285	downregulated	Cytarabine results in decreased expression of B4GALT7 mRNA	5q35.3	A21886
Cytarabine	Approved Investigational	BAG3	9531	downregulated	Cytarabine results in decreased expression of BAG3 mRNA	10q26.11	A21886
Cytarabine	Approved Investigational	BAIAP2L1	55971	downregulated	Cytarabine results in decreased expression of BAIAP2L1 mRNA	7q21.3-q22.1	A21886
Cytarabine	Approved Investigational	BCAR3	8412	downregulated	Cytarabine results in decreased expression of BCAR3 mRNA	1p22.1	A21886
Cytarabine	Approved Investigational	BCAS4	55653	downregulated	Cytarabine results in decreased expression of BCAS4 mRNA	20q13.13	A21886
Cytarabine	Approved Investigational	BCL2	596	downregulated	Cytarabine results in decreased expression of BCL2 mRNA	18q21.33	A21887
Cytarabine	Approved Investigational	BHLHE22	27319	upregulated	Cytarabine results in increased expression of BHLHE22 mRNA	8q12.3	A21886
Cytarabine	Approved Investigational	BIN2	51411	upregulated	Cytarabine results in increased expression of BIN2 mRNA	12q13.13	A20985
Cytarabine	Approved Investigational	BMP4	652	downregulated	Cytarabine results in decreased expression of BMP4 mRNA	14q22.2	A21886
Cytarabine	Approved Investigational	BMP5	653	downregulated	Cytarabine results in decreased expression of BMP5 mRNA	6p12.1	A21886
Cytarabine	Approved Investigational	BNC1	646	downregulated	Cytarabine results in decreased expression of BNC1 mRNA	15q25.2	A21886
Cytarabine	Approved Investigational	BNC2	54796	downregulated	Cytarabine results in decreased expression of BNC2 mRNA	9p22.3-p22.2	A21886
Cytarabine	Approved Investigational	BORA	79866	downregulated	Cytarabine results in decreased expression of BORA mRNA	13q21.33	A20666
Cytarabine	Approved Investigational	BRCA2	675	upregulated	Cytarabine results in increased expression of BRCA2 mRNA	13q13.1	A20985
Cytarabine	Approved Investigational	BST2	684	downregulated	Cytarabine results in decreased expression of BST2 mRNA	19p13.11	A21886
Cytarabine	Approved Investigational	C2CD2	25966	downregulated	Cytarabine results in decreased expression of C2CD2 mRNA	21q22.3	A21886
Cytarabine	Approved Investigational	C3AR1	719	upregulated	Cytarabine results in increased expression of C3AR1 mRNA	12p13.31	A20985
Cytarabine	Approved Investigational	CA12	771	downregulated	Cytarabine results in decreased expression of CA12 mRNA	15q22.2	A21886
Cytarabine	Approved Investigational	CAB39L	81617	downregulated	Cytarabine results in decreased expression of CAB39L mRNA	13q14.2	A21886
Cytarabine	Approved Investigational	CALB2	794	downregulated	Cytarabine results in decreased expression of CALB2 mRNA	16q22.2	A21886
Cytarabine	Approved Investigational	CAMK2N1	55450	upregulated	Cytarabine results in increased expression of CAMK2N1 mRNA	1p36.12	A21886
Cytarabine	Approved Investigational	CAPN1	823	downregulated	Cytarabine results in decreased expression of CAPN1 mRNA	11q13.1	A21886
Cytarabine	Approved Investigational	CARMIL1	55604	downregulated	Cytarabine results in decreased expression of CARMIL1 mRNA	6p22.2	A21886

Displaying entries 28301 - 28325 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability